LifeMD (LFMD) Competitors $5.74 +0.02 (+0.35%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$5.70 -0.04 (-0.63%) As of 01/30/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LFMD vs. GRAL, CSTL, AUNA, TALK, FLGT, INNV, DCGO, EHAB, CELC, and PSNLShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Grail (GRAL), Castle Biosciences (CSTL), Auna (AUNA), Talkspace (TALK), Fulgent Genetics (FLGT), InnovAge (INNV), DocGo (DCGO), Enhabit (EHAB), Celcuity (CELC), and Personalis (PSNL). These companies are all part of the "healthcare" industry. LifeMD vs. Grail Castle Biosciences Auna Talkspace Fulgent Genetics InnovAge DocGo Enhabit Celcuity Personalis LifeMD (NASDAQ:LFMD) and Grail (NASDAQ:GRAL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability. Is LFMD or GRAL more profitable? Grail has a net margin of 0.00% compared to LifeMD's net margin of -12.06%. Company Net Margins Return on Equity Return on Assets LifeMD-12.06% N/A -36.34% Grail N/A N/A N/A Do analysts recommend LFMD or GRAL? LifeMD presently has a consensus target price of $11.14, suggesting a potential upside of 94.13%. Grail has a consensus target price of $16.00, suggesting a potential downside of 49.22%. Given LifeMD's stronger consensus rating and higher possible upside, research analysts plainly believe LifeMD is more favorable than Grail.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Grail 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable valuation and earnings, LFMD or GRAL? Grail has lower revenue, but higher earnings than LifeMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$152.55M1.63-$20.60M-$0.64-8.97Grail$117.67M9.00N/AN/AN/A Does the media favor LFMD or GRAL? In the previous week, Grail had 9 more articles in the media than LifeMD. MarketBeat recorded 12 mentions for Grail and 3 mentions for LifeMD. LifeMD's average media sentiment score of 1.21 beat Grail's score of 0.57 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Grail 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in LFMD or GRAL? 35.5% of LifeMD shares are owned by institutional investors. 16.0% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer LFMD or GRAL? LifeMD received 36 more outperform votes than Grail when rated by MarketBeat users. Likewise, 75.00% of users gave LifeMD an outperform vote while only 0.00% of users gave Grail an outperform vote. CompanyUnderperformOutperformLifeMDOutperform Votes3675.00% Underperform Votes1225.00% GrailOutperform VotesNo VotesUnderperform Votes3100.00% SummaryLifeMD beats Grail on 9 of the 13 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$248.60M$1.22B$5.61B$9.14BDividend YieldN/AN/A5.36%3.98%P/E Ratio-8.9715.4089.6917.66Price / Sales1.631.901,217.4681.09Price / CashN/A38.7544.3437.71Price / Book38.279.335.134.73Net Income-$20.60M-$52.07M$118.85M$225.42M7 Day Performance11.89%6.98%1.40%0.75%1 Month Performance15.96%33.98%7.53%3.61%1 Year Performance2.68%10.16%26.68%21.42% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD2.2839 of 5 stars$5.74+0.3%$11.14+94.1%+3.2%$248.60M$152.55M-8.97230GRALGrail0.3759 of 5 stars$25.99-9.2%$16.00-38.4%N/A$873.26MN/A0.001,360Short Interest ↑Gap UpCSTLCastle Biosciences3.2644 of 5 stars$26.65+0.8%$40.29+51.2%+17.8%$746.47M$219.79M133.26540AUNAAunaN/A$8.49+3.2%$13.40+57.8%N/A$627.58M$1.04B0.0014,958Short Interest ↓TALKTalkspace3.8308 of 5 stars$3.19-0.3%$4.38+37.1%+30.8%$538.86M$150.04M-319.00500Short Interest ↑FLGTFulgent Genetics3.8634 of 5 stars$17.41+1.2%$22.00+26.4%-32.0%$532.57M$289.21M-3.151,184Short Interest ↑INNVInnovAge1.6129 of 5 stars$3.76+0.8%$6.00+59.6%-29.5%$509.33M$763.85M-31.332,350Upcoming EarningsShort Interest ↓Positive NewsDCGODocGo2.7406 of 5 stars$4.74-4.0%$6.10+28.7%+42.2%$483.72M$624.29M16.934,164Positive NewsEHABEnhabit1.9322 of 5 stars$8.46+4.0%$8.75+3.5%-15.5%$425.15M$1.04B-3.6410,800Short Interest ↓Positive NewsCELCCelcuity1.5704 of 5 stars$11.35-0.6%$29.17+157.0%-22.9%$421.43MN/A-4.3540PSNLPersonalis4.1672 of 5 stars$5.81-5.1%$7.81+34.5%+282.9%$410.48M$73.48M-3.46400Analyst Revision Related Companies and Tools Related Companies Grail Competitors Castle Biosciences Competitors Auna Competitors Talkspace Competitors Fulgent Genetics Competitors InnovAge Competitors DocGo Competitors Enhabit Competitors Celcuity Competitors Personalis Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LFMD) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
